These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9855417)

  • 21. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge.
    Chinchilli VM; Fisher L; Craig TJ
    J Allergy Clin Immunol; 2005 Mar; 115(3):592-7. PubMed ID: 15753909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bridging studies.
    Fritzell B
    Dev Biol Stand; 1998; 95():181-8. PubMed ID: 9855430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How first-time-in-human studies are being performed: a survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004.
    Buoen C; Bjerrum OJ; Thomsen MS
    J Clin Pharmacol; 2005 Oct; 45(10):1123-36. PubMed ID: 16172177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase III trials in oncology].
    Imadalou K; Cvitkovic E
    Bull Cancer; 1999 Feb; 86(2):143-7. PubMed ID: 10066944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pneumococcal vaccine. Its efficacy in patients 55 and over].
    Marchand R
    Can Fam Physician; 1993 May; 39():1144-9. PubMed ID: 8499794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factorial dose-response studies using frequency and magnitude of dose.
    Hafner KB; Ruberg SJ
    J Biopharm Stat; 1996 Jul; 6(3):253-62. PubMed ID: 8854230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuing education. Clinical trials].
    Sökeland J
    Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulatory aspects of clinical trials with vaccines.
    Georges AM
    Dev Biol Stand; 1998; 95():69-74. PubMed ID: 9855416
    [No Abstract]   [Full Text] [Related]  

  • 38. Joint reviews and inspections: strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa.
    Maïga D; Akanmori BD; Chocarro L
    Vaccine; 2009 Dec; 28(2):571-5. PubMed ID: 19833249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomisation in double-blind multicentre trials with many treatments.
    Morrissey M; McEntegart D; Lang M
    Contemp Clin Trials; 2010 Jul; 31(4):381-91. PubMed ID: 20460174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of a French hepatitis B vaccine. Results of a multicenter clinical trial, using a placebo, with double-blind randomized administration].
    Crosnier J; Jungers P; Courouce AM; Laplanche A; Benhamou E; Degos F; Lacour B; Guesry P
    Bull Acad Natl Med; 1980 Nov; 164(8):764-76. PubMed ID: 7011486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.